|
FLT3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.728500E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.071180E-01 |
| Normal-vs-Stage2 |
9.362100E-02 |
| Normal-vs-Stage3 |
3.138600E-01 |
| Normal-vs-Stage4 |
1.572770E-01 |
| Stage1-vs-Stage2 |
7.382400E-01 |
| Stage1-vs-Stage3 |
7.427600E-01 |
| Stage1-vs-Stage4 |
9.371600E-01 |
| Stage2-vs-Stage3 |
6.211600E-01 |
| Stage2-vs-Stage4 |
8.991200E-01 |
| Stage3-vs-Stage4 |
7.314600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.101600E-02 |
| Normal-vs-AfricanAmerican |
7.128800E-01 |
| Normal-vs-Asian |
8.023900E-03 |
| Caucasian-vs-AfricanAmerican |
6.628300E-04 |
| Caucasian-vs-Asian |
4.836400E-02 |
| AfricanAmerican-vs-Asian |
6.00720000000221E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.332400E-02 |
| Normal-vs-Female |
2.029200E-01 |
| Male-vs-Female |
3.210600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.945200E-01 |
| Normal-vs-Extreme_Weight |
1.572370E-02 |
| Normal-vs-Obese |
2.144200E-01 |
| Normal-vs-Extreme_Obese |
7.563200E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.075780E-01 |
| Normal_Weight-vs-Obese |
9.538000E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.019400E-01 |
| Extreme_Weight-vs-Obese |
6.262600E-03 |
| Extreme_Weight-vs-Extreme_Obese |
1.754990E-01 |
| Obese-vs-Extreme_Obese |
3.922800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.755600E-01 |
| Normal-vs-Age(41-60Yrs) |
1.400020E-01 |
| Normal-vs-Age(61-80Yrs) |
4.436400E-02 |
| Normal-vs-Age(81-100Yrs) |
4.403400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.206400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.146200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.505000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.531600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.434200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.011600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.111800E-01 |
| Normal-VS-Type2 PRCC |
6.083500E-02 |
| Normal-VS-KIRP CIMP |
9.138600E-01 |
| Normal-VS-Unclassified PRCC |
2.095400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
6.708400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.900360E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.794800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.386400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.221400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.740000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.432300E-02 |
| Normal-vs-N1 |
2.031800E-01 |
| Normal-vs-N2 |
2.916900E-03 |
| N0-vs-N1 |
1.642210E-01 |
| N0-vs-N2 |
3.659700E-02 |
| N1-vs-N2 |
1.607890E-02 |
|
|
